Most development plans are built one function at a time. Nonclinical designs the tox program. CMC builds a process to supply it. Regulatory writes a strategy around what’s been done. Quality audits the result. Each step is sound. The plan, taken as a whole, often isn’t.
Playbook
The Integrated Development Roadmap Playbook
Related Resources
All Resources
case-study
U.S. Based Independent Biotech Company Finds Success in Syner-G’s Capabilities in Manufacturing for Both Pre-Clinical and Clinical Trials Case Studies
Read More
post
Understanding Large Molecule Manufacturing: From Biologics to Market
Read More
case-study
Successful Partnership Improved Efficiencies and Reduced Overall Spend
Read More
post
Formulation Strategies for Large Molecule Drug Products
Read More
Let's move from science to success.
Let’s Talk